## TSN: Tyson Foods, Inc. - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 0.44 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.7% MRS), overbought RSI (70).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($55.66)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Tyson Foods, Inc. $TSN Shares Sold by JPMorgan Chase & Co.**
- Source: MarketBeat | 20251201T102414 | Somewhat-Bullish | Relevance: 99%
- JPMorgan Chase & Co. reduced its stake in Tyson Foods (NYSE:TSN) by 11.2% in Q2, selling 136,133 shares. This reduction leaves them with 1,083,509 shares, representing approximately 0.30% ownership valued at $60.6 million. Despite this, Tyson Foods reported topping EPS estimates but missed revenue expectations, and institutional ownership remains high.

**2. Tyson Foods chairman sells $5.8m in class A common stock**
- Source: Investing.com | 20251201T133100 | Neutral | Relevance: 98%
- John H. Tyson, Chairman of Tyson Foods, sold 100,301 shares of Class A Common Stock for over $5.8 million, while also exercising options to acquire additional shares. These transactions occurred as the stock trades near $58.37, with analysis suggesting it may be undervalued. The company recently reported strong Q4 2025 earnings but missed revenue expectations and is closing a significant beef processing plant.

**3. Tyson Foods chairman sells $5.8m in class A common stock By Investing.com**
- Source: Investing.com South Africa | 20251201T203200 | Neutral | Relevance: 97%
- John H. Tyson, Chairman of the Board at Tyson Foods Inc., sold 100,301 shares of Class A Common Stock for over $5.8 million while also exercising options to acquire an additional 109,202 shares. This transaction occurred amidst recent company developments, including exceeding fourth-quarter EPS estimates despite a revenue miss, and the closure of a beef processing plant in Nebraska. Analysts have adjusted price targets for Tyson Foods, maintaining "Market Perform" ratings and viewing the plant closure as a strategic move to improve industry margins.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | BMO Capital | $56 | $53 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 15 ($5.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.1%)
- Blackrock Inc.: 9.2% (-1.7%)
- State Street Corpora: 5.0% (+0.6%)
- Pzena Investment Man: 4.9% (+0.9%)
- Davis Selected Advis: 3.5% (+11.2%)

### Key Risks

1. Insider selling cluster: $5.8M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.44 indicates undervaluation relative to growth. Forward P/E 13.1x attractive for 15% earnings growth. Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.4B |
| Beta | 0.46 |
| 52W Range | $50.56 - $64.36 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.44 |
| Forward P/E | 13.1 |
| Current P/E | 15.0 |
| YoY Growth | 14.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 8.9% to 6.2% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 94th percentile. MRS_5 at 0.8% confirms short-term momentum alignment. AM_20 at 7.4% shows strong absolute momentum above own 20MA. Outperforming sector by 4.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.57), confirming momentum. RSI overbought at 70, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.23% (CS: 94) | Strong |
| RSI_14 | 70.4 | Overbought |
| MACD Histogram | 0.57 | Bullish |
| vs SMA20 | 1.073x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 1.034x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $58.30
- **Stop Loss:** $55.66 (4.5% risk)
- **Target:** $63.58 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 454
- **Position Value:** $26,468.20
- **Portfolio %:** 26.47%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-02 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.83 | $1.15 | +37.8% |
| 2025Q2 | $0.78 | $0.91 | +16.2% |
| 2025Q1 | $0.82 | $0.92 | +12.2% |
| 2024Q4 | $0.88 | $1.14 | +29.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*